about
GSK-3 as potential target for therapeutic intervention in cancerHSV-1 and Alzheimer's disease: more than a hypothesis.Therapeutic Targeting of AutophagyAutophagy in neurodegenerative diseases: from mechanism to therapeutic approachLong-term lithium treatment reduces glucose metabolism in the cerebellum and hippocampus of nondemented older adults: an [¹⁸F]FDG-PET studyEarly investigational drugs targeting tau protein for the treatment of Alzheimer's diseaseLithium efficacy in bipolar depression with flexible dosing: A six-week, open-label, proof-of-concept studyLithium enhances survival and regrowth of spinal motoneurons after ventral root avulsion.Lack of evidence of the interaction of the Aβ peptide with the Wnt signaling cascade in Drosophila models of Alzheimer's diseaseNeurodegenerative changes in rat produced by lithium treatment.Glycogen synthase kinase 3β orchestrates microtubule remodeling in compensatory glomerular adaptation to podocyte depletion.Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders.Lithium: a versatile tool for understanding renal physiology.Effects of lithium on cortical thickness and hippocampal subfield volumes in psychotic bipolar disorder.Long-term lithium treatment in bipolar disorder is associated with longer leukocyte telomeres.Lithium chloride promotes host resistance against Pseudomonas aeruginosa keratitis.Lithium chloride could aggravate brain injury caused by 3-nitropropionic acid.Neurotoxic saboteurs: straws that break the hippo's (hippocampus) back drive cognitive impairment and Alzheimer's Disease.Glycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments.Characterization of biometal profiles in neurological disorders.GSK-3β, a pivotal kinase in Alzheimer disease.Standard and trace-dose lithium: a systematic review of dementia prevention and other behavioral benefits.Dietary regulation of PI3K/AKT/GSK-3β pathway in Alzheimer's disease.Brain-Derived Neurotrophic Factor in Alzheimer's Disease: Risk, Mechanisms, and Therapy.Glycogen synthase kinase-3 as a therapeutic target for cognitive dysfunction in neuropsychiatric disorders.Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseasesIn vitro antiviral effect of germacrone on feline calicivirus.Antiviral effect of lithium chloride on feline calicivirus in vitro.Prasugrel suppresses development of lithium-induced nephrogenic diabetes insipidus in mice.Effects of lithium and valproic acid on BDNF protein and gene expression in an in vitro human neuron-like model of degeneration.Lithium prevents acrolein-induced neurotoxicity in HT22 mouse hippocampal cells.Lithium activates brain phospholipase A2 and improves memory in rats: implications for Alzheimer's disease.A negative association between lithium in drinking water and the incidences of homicides, in Greece.Roles of PI3K/AKT/GSK3/mTOR Pathway in Cell Signaling of Mental Illnesses.In vivo modification of Abeta plaque toxicity as a novel neuroprotective lithium-mediated therapy for Alzheimer's disease pathology.Impact of lithium treatment on FGF-23 serum concentrations in depressive patients.Chronic Lithium Treatment in a Rat Model of Basal Forebrain Cholinergic Depletion: Effects on Memory Impairment and Neurodegeneration.Autophagy and Alzheimer's Disease: From Molecular Mechanisms to Therapeutic Implications.GSK3β Regulates Brain Energy Metabolism.Neurodegenerative Diseases: Regenerative Mechanisms and Novel Therapeutic Approaches
P2860
Q27013811-539DA867-8BCC-432B-A66E-98B597E80795Q27692651-8D6261B6-2D54-4DC8-9626-83453C54F547Q28078117-AB3B8DBF-1464-4820-8627-C12C4B5FED1EQ28084605-106272F1-FFF4-4EDC-85A7-DF55E2B6C92CQ33777999-C75AAB43-014B-497B-A997-A55E617EAD6CQ33887379-C4B2DB3D-0060-4F18-920B-9B802DE01F59Q34119673-13244218-C883-4008-ABA3-2879E6B51C61Q34485199-66605D63-6676-4782-BDF7-1C60BCC88A9AQ34515555-4EEAD662-492C-44DD-B587-14376CE6E186Q34628356-9AB13336-8A82-45A1-A18B-32A529F94BCEQ35121215-2038F5E6-48FD-46F5-B9B0-FDFAFA852021Q36769080-CF30DA8C-669D-4DE0-B4B1-2203A12A646BQ36836247-FF7CAC21-ABFB-4E89-8A38-5ADCA4E10235Q36879689-D96CBD77-A8E9-42CD-9FF8-8088C73B7281Q36894284-D1A6799F-CAF1-419B-82DD-A656C971B8CBQ37027482-09207F9F-0B43-4C39-B56C-98CCCADEE363Q37471801-F22CCDA7-6EB9-48BE-BA1E-4983E0F4820DQ38118901-41766BAC-F0CA-4CDC-8C31-9DF8742D7D2FQ38126701-87E1D2C3-3A51-493A-A9F0-4CFB6B073AF5Q38197094-1E6D4BE6-3A91-4604-9C4D-F1DDD0C1DA94Q38218085-1B35D256-9521-4774-9B01-3AE5FD7B6ED7Q38219564-E3A7AD19-A27C-47C9-99E6-1482869EE475Q38230391-D0FB9358-C6ED-44B4-A2B1-D6F3F0C0E53BQ38263685-1B2DE54A-12EF-4D84-A36A-DEC39C7D0A71Q38266162-1F0D3E10-9645-48F9-A27F-F9AC004A2F18Q38272835-DA9FD3BC-0FE1-409D-81F1-1EE434992EDCQ38784611-61E3FABD-974D-42B5-B99E-2BD1081759A2Q38846631-83F1A675-B243-43FF-A71D-259B180A7246Q38944892-95DE2D94-EFE1-4182-B686-C156341949D9Q39008341-DFD296CB-A93C-4866-9176-2F3CE368899FQ39024430-81EC8F9D-15CF-4314-9332-BB85C26965C1Q40217838-7F9E5387-BAC5-4D5D-9863-265C6F3F289AQ41628266-A7BFF44F-7AC4-4AC7-885F-8FF229A8343CQ42527577-B6CF1FFA-7EED-4757-B245-EF55B4188DE0Q42762188-33248C18-AE6B-41EF-A951-CA2B89AD1978Q43134207-C970BF87-6AE9-4C79-9129-F767BD636CD6Q47981799-75FEADD4-AA2B-4681-A63B-7E1F0BC7FB48Q50023771-11DF4196-172F-4177-BC09-80C28FE0A7C3Q54978936-371A6009-2E80-4531-8282-11EED85CAC58Q58737028-70D87FB7-ED63-4FA9-9FE3-54D93EF3E51A
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Does lithium prevent Alzheimer's disease?
@ast
Does lithium prevent Alzheimer's disease?
@en
Does lithium prevent Alzheimer's disease?
@nl
type
label
Does lithium prevent Alzheimer's disease?
@ast
Does lithium prevent Alzheimer's disease?
@en
Does lithium prevent Alzheimer's disease?
@nl
prefLabel
Does lithium prevent Alzheimer's disease?
@ast
Does lithium prevent Alzheimer's disease?
@en
Does lithium prevent Alzheimer's disease?
@nl
P2093
P2860
P1433
P1476
Does lithium prevent Alzheimer's disease?
@en
P2093
Orestes V Forlenza
Vanessa J de Paula
Wagner F Gattaz
P2860
P304
P356
10.2165/11599180-000000000-00000
P577
2012-05-01T00:00:00Z
P5875
P6179
1014888309